Publication:
Comparison of the Effectiveness of Rituximab Versus Alemtuzumab and Natalizumab in Active Relapsing-Remitting MS

Research Projects

Organizational Units

Journal Issue

Abstract

Description

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS -- SEP 11-13, 2019 -- Stockholm, SWEDEN

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

25

Issue

Start Page

912

End Page

914

Endorsement

Review

Supplemented By

Referenced By